Literature DB >> 25133041

Visceral hypersensitivity and electromechanical dysfunction as therapeutic targets in pediatric functional dyspepsia.

John M Rosen1, Jose T Cocjin1, Jennifer V Schurman1, Jennifer M Colombo1, Craig A Friesen1.   

Abstract

Functional gastrointestinal disorders (FGID) are common clinical syndromes diagnosed in the absence of biochemical, structural, or metabolic abnormalities. They account for significant morbidity and health care expenditures and are identifiable across variable age, geography, and culture. Etiology of abdominal pain associated FGIDs, including functional dyspepsia (FD), remains incompletely understood, but growing evidence implicates the importance of visceral hypersensitivity and electromechanical dysfunction. This manuscript explores data supporting the role of visceral hypersensitivity and electromechanical dysfunction in FD, with focus on pediatric data when available, and provides a summary of potential therapeutic targets.

Entities:  

Keywords:  Functional dyspepsia; Motility; Visceral hypersensitivity

Year:  2014        PMID: 25133041      PMCID: PMC4133438          DOI: 10.4292/wjgpt.v5.i3.122

Source DB:  PubMed          Journal:  World J Gastrointest Pharmacol Ther        ISSN: 2150-5349


  201 in total

1.  Influence of motilin on gastric fundus tone and on meal-induced satiety in man: role of cholinergic pathways.

Authors:  Rosario Cuomo; Pieter Vandaele; Bernard Coulie; Theo Peeters; Inge Depoortere; Jozef Janssens; Jan Tack
Journal:  Am J Gastroenterol       Date:  2006-04       Impact factor: 10.864

Review 2.  Dysaccommodation of the stomach: therapeutic nirvana?

Authors:  R Bisschops; J Tack
Journal:  Neurogastroenterol Motil       Date:  2007-02       Impact factor: 3.598

3.  Effect of the 5-HT3 receptor antagonist, ondansetron, on gastric size in dyspeptic patients with impaired gastric accommodation.

Authors:  L Marzio; G Cappello; L Grossi; L Manzoli
Journal:  Dig Liver Dis       Date:  2008-01-31       Impact factor: 4.088

4.  Efficacy and safety of cinitapride in the treatment of mild to moderate postprandial distress syndrome-predominant functional dyspepsia.

Authors:  Yiqi Du; Tun Su; Xinmiao Song; Jun Gao; Duowu Zou; Changjing Zuo; Weifen Xie; Bangmao Wang; Zhiguang Zhang; Jianming Xu; Dean Tian; Hesheng Luo; Zhenyu Zhang; Shaofeng Wang; Jianping Chen; Jizhong Guo; Lei Gong; Yanbing Ding; Zhaoshen Li
Journal:  J Clin Gastroenterol       Date:  2014-04       Impact factor: 3.062

5.  Evidence for hypomotility in non-ulcer dyspepsia: a prospective multifactorial study.

Authors:  B Waldron; P T Cullen; R Kumar; D Smith; J Jankowski; D Hopwood; D Sutton; N Kennedy; F C Campbell
Journal:  Gut       Date:  1991-03       Impact factor: 23.059

Review 6.  Functional gastroduodenal disorders.

Authors:  Jan Tack; Nicholas J Talley; Michael Camilleri; Gerald Holtmann; Pinjin Hu; Juan-R Malagelada; Vincenzo Stanghellini
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

7.  Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.

Authors:  Toru Hiyama; Masaharu Yoshihara; Keitaro Matsuo; Hiroaki Kusunoki; Tomoari Kamada; Masanori Ito; Shinji Tanaka; Nobuo Nishi; Kazuaki Chayama; Ken Haruma
Journal:  J Gastroenterol Hepatol       Date:  2007-03       Impact factor: 4.029

8.  Nizatidine improves clinical symptoms and gastric emptying in patients with functional dyspepsia accompanied by impaired gastric emptying.

Authors:  S Futagami; M Shimpuku; J M Song; Y Kodaka; H Yamawaki; H Nagoya; T Shindo; T Kawagoe; A Horie; K Gudis; K Iwakiri; C Sakamoto
Journal:  Digestion       Date:  2012-07-27       Impact factor: 3.216

9.  Subtypes and Symptomatology of Irritable Bowel Syndrome in Children and Adolescents: A School-based Survey Using Rome III Criteria.

Authors:  Shaman Rajindrajith; Niranga M Devanarayana
Journal:  J Neurogastroenterol Motil       Date:  2012-07-10       Impact factor: 4.924

10.  Effect of a tricyclic antidepressant on small intestinal motility in health and diarrhea-predominant irritable bowel syndrome.

Authors:  D A Gorard; G W Libby; M J Farthing
Journal:  Dig Dis Sci       Date:  1995-01       Impact factor: 3.199

View more
  7 in total

1.  Present state and future challenges in pediatric abdominal pain therapeutics research: Looking beyond the forest.

Authors:  Craig A Friesen; Jennifer V Schurman; Susan M Abdel-Rahman
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

2.  Enhanced sympathetic nerve activity induced by neonatal colon inflammation induces gastric hypersensitivity and anxiety-like behavior in adult rats.

Authors:  John H Winston; Sushil K Sarna
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-05-05       Impact factor: 4.052

3.  Therapeutic effect of melatonin on pediatric functional dyspepsia: A pilot study.

Authors:  Katherine Zybach; Craig A Friesen; Jennifer V Schurman
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

4.  Noninflammatory upregulation of nerve growth factor underlies gastric hypersensitivity induced by neonatal colon inflammation.

Authors:  Qingjie Li; John H Winston; Sushil K Sarna
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-11-25       Impact factor: 3.619

Review 5.  Functional Nausea in Children: A Review of the Literature and Need for Diagnostic Criteria.

Authors:  Alexandra C Russell; Amanda L Stone; Lynn S Walker
Journal:  Children (Basel)       Date:  2016-03-10

Review 6.  Choosing an Animal Model for the Study of Functional Dyspepsia.

Authors:  Yang Ye; Xue-Rui Wang; Yang Zheng; Jing-Wen Yang; Na-Na Yang; Guang-Xia Shi; Cun-Zhi Liu
Journal:  Can J Gastroenterol Hepatol       Date:  2018-02-12

Review 7.  Perspectives on the clinical significance of functional pain syndromes in children.

Authors:  Molly C Basch; Erika T Chow; Deirdre E Logan; Neil L Schechter; Laura E Simons
Journal:  J Pain Res       Date:  2015-10-07       Impact factor: 3.133

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.